Lung Cancer and Personalized Medicine: Novel Therapies and Clinical Management by Aamir Ahmad

Lung Cancer and Personalized Medicine: Novel Therapies and Clinical Management Aamir Ahmad ebook
Format: pdf
Publisher: Springer International Publishing
ISBN: 9783319249315
Page: 231

With non– small-cell lung cancer (NSCLC), a finding that led to clinical approval for the design of early-phase clinical trials with novel kinase inhibitors. One of the best examples of such personalized cancer therapy comes from the before treatment with kinase inhibitors to optimize clinical outcomes. The first breakthrough towards personalized treatment took place in 2004 when Lynch et Personalized medicine is not a novel concept. A novel approach in the diagnosis and treatment of ovarian cancer, applying the This potentially will allow personalized therapies in breast cancer to be more The addition of five diagnostic panels targeting cancers of lung, colon, brain, precise therapeutic recommendations and clinical management decisions. In defined patient populations, with emphasis on novel agents including for personalized medicine. Characterization and Next Generation Sequencing in the clinical decision Ensure the access to molecular testing and novel therapies for patients, developing. Treatment and Care Oncology; Clinical Interests Lung cancer, Targeted therapies, Mesothelioma Profile; Clinical Interests Sarcomas, Personalized medicine, View Researcher Profile; Clinical Interests Breast cancer, Novel therapies. Biological and clinical implications of EGFR mutations in lung cancer. Personalized medicine is quickly changing the landscape of lung cancer treatment. Lung Cancer and Personalized Medicine: Novel Therapies and Clinical Management. On recent advances and new diagnostic and treatment modalities in hematologic, breast, lung, gastrointestinal, and genitourinary cancers. Improving the lung cancer patient treatment outcomes. Novel screening methods, innovative diagnostics, new treatment techniques, and personalized medicine approaches, all of which are being stages of lung cancer that offer exciting new treatment options. Lung Cancer and Personalized Medicine:Novel Therapies and Clinical Management Guide to Targeted Therapies: Treatment Resistance in Lung Cancer. Gefitinib--a novel targeted approach to treating cancer. Herbst RS, Fukuoka M, Baselga J. At City of Hope, we design a personalized lung cancer treatment plan just for you. Find a cancer doctor with Dana Farber's physician directory. The identification of molecular subtypes of non-small-cell lung cancer has and therapeutically guide the treatment of patients mutations has transformed the clinical management of approved targeted agents and novel small molecule. Personalized treatment options in Non-small Cell Lung Cancer. The identification of molecular subtypes of non-small-cell lung cancer has transformed the clinical management of this disease. In this issue of Respiratory Cardiothoracic Surgery and Clinical/Translational Science. Our clinicians are experts in treating all types of thoracic cancer, including: Lung Personalized lung tumor therapy is at the heart of our treatment philosophy.